Skip to main content
. 2014 Sep 4;2014:830847. doi: 10.1155/2014/830847

Figure 6.

Figure 6

The probability of survival of stomach cancer patients in relation to the level of TF-specific antibodies and their SNA reactivity. Patients with either lower, equal (a dashed line), or higher values (level of Abs or SNA binding) than median (a solid line) are compared using the Kaplan-Meier method. HR: hazard ratio with 95% confidence interval and P values are shown. (a) Anti-TF IgG level and survival of patients in stages 3-4 of the disease. (b) Anti-TF IgM level and survival of cancer patients (stages 1–4). (c) SNA/anti-TF IgM index (all patients). (d) SNA/anti-TF IgM index (patients with intestinal tumors).